The shape/morphology balance: A study of stealth liposomes via fractal analysis and drug encapsulation

Pharmaceutical Research

Volumn 30, Issue 9, 2013, Pages 2385-2395

  Pippa, Natassa ^a,b   Psarommati, Faidra ^a   Pispas, Stergios ^b   Demetzos, Costas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b THEORETICAL AND PHYSICAL CHEMISTRY INSTITUTE   (Greece)

Author keywords

fractal dimension; indomethacin; morphology; pegylated nanoparticles; shape

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; INDOMETACIN; LIPOSOME; MACROGOL 3000;

ARTICLE; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; FLUORESCENCE SPECTROSCOPY; FRACTAL ANALYSIS; HYDRODYNAMICS; LIGHT SCATTERING; LIPOSOMAL DELIVERY; MICROFLUIDITY; MICROPOLARITY; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SURFACE CHARGE; TEMPERATURE SENSITIVITY; THERMOSTABILITY;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FRACTALS; INDOMETHACIN; LIPOSOMES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS;

EID: 84883297826     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1082-8     Document Type: Article

References (56)

1. Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ. Nanotechnology: a focus on nanoparticles as drug delivery system. J Neuroimmume Pharmacol. 2006;1:340-50.
2. Kayser O, Lemke A, Hernández-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechol. 2005;6(1):3-5.
3. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol. 2008;26(1):74-85.
4. Rawat M, Singh D, Saraf S, Saraf S. Nanocarriers: promising vesicle for bioactive drugs. Biol Pharm Bull. 2006;29(9):1790-8.
5. Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy. J Chemother. 2004;16(4):94-7.
6. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 2006;1(3):297-315.
7. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 2003;42(6):463-78.
8. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv. 2007;4(4):297-305.
9. Mufamadi MS, Pillay V, Choonara YE, Du Toit LC, GirishModi G, Naidoo D, et al. A review on composite liposomal technologies for specialized drug delivery. J Drug Delivery. 2011;2011:939851-70.
10. 2+. Eur Phys J E. 2007;24:201-10.
11. 3+: a study of the fractal dimension. Phys Rev E. 2007;76(011408):1-7.
12. Roldán-Vargas S, Barnabas-Rodrígez R, Martín-Molina A, Quesada-Pérez M, Estelrich J, Callejas-Fernández J. Growth of lipid vesicle structures: from surface fractals to mass fractals. Phys Rev E. 2008;78(010902(R)):1-4.
13. Roldán-Vargas S, Barnabas-Rodrígez R, Quesada-Pérez M, Estelrich J, Callejas-Fernández J. Surface fractals in liposome aggregation. Am Phys Soc Phys Rev. 2009;79:1-14.
14. Pippa N, Pispas S, Demetzos C. The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media. Int J Pharm. 2012;430(1-2):65-73.
15. Pippa N, Pispas S, Demetzos C. The delineation of the morphology of charged liposomal vectors via fractal analysis in aqueous and biological media: Physicochemical and self-assembly studies. Int J Pharm. 2012;437:264-74.
16. Derjaguin BV, Landau LD. Theory of the stability of stronglycharged lyophobic sols and of adhesion of strongly charged particles in solution of electrolytes. Acta Physicochim URRS. 1941;14:633-62.
17. Verwey EJB, Overbeek JTHG. Theory of the stability of lyophobic colloids. Amsterdan: Elsevier; 1948. p. 108.
18. 3+ on the colloidal stability of liposomes. Langmuir. 2005;21:10968-75.
19. Sabín J, Prieto G, Ruso JM, Hidalgo-Álvarez R, Sarmiento F. Size and stability of liposomes: a possible role of hydration and osmotic forces. Eur Phys JE. 2006;20:401-8.
20. Lin MY, Lindsay HM, Weitz DA, Klein R, Ball RC, Meakin P. Universal reaction - limited colloid aggregation. Nature. 1989;339:360-2.
21. Gregory J. Monitoring particle aggregation processes. Adv Colloid Interface Sci. 2009;147-148:109-23.
22. Soh JW, Weinstein IB. Role of COX-indepedent targets of NSAIDs and related coumpounds in cancer prevention and treatment. Prog Exp Tumor Res. 2003;37:261-85.
23. Xu XC. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs. 2002;13(2):127-37.
24. Rao CV, Reddy BS. NSAIDs and chemoprevention. Curr Cancer Drug Targets. 2004;4(1):29-42.
25. Caruso I, Bianchi PG. Gastroscopic evaluation of anti-inflammatory agents. Br Med J. 1980;280(6207):75-8.
26. Morris AD, Holt SD, Silvoso GR, Hewitt J, Tatum W, Grandione J, et al. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol Suppl. 1981;67:131-5.
27. Zhou Y, Dial EJ, Doyen R, Lichtenberger LM. Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G722-731.
28. Soehngen EC, Godin-Ostro E, Fielder FG, Ginsberg RS, Slusher MA, Weiner AL. Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis Rheum. 1988;31(3):414-22.
29. Chen H, Gao J, Wang F, Liang W. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv. 2007;14(4):201-8.
30. Milonaki Y, Kaditi E, Pispas S, Demetzos C. Amphiphilic gradient copolymers of 2-methyl- and 2-phenyl-2-oxazoline: self-organization in aqueous media and drug encapsulation. J Polymer Sci, Part A: Polymer Chem. 2011;50:1226-37.
31. Jaafar-Maalej C, Charcosset C, Fessi H. A new method for liposome preparation using a membrane contactor. J Liposome Res. 2011;21(3):213-20.
32. Sugihara H, Yamamoto H, Kawashima Y, Takeuchi H. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin. J Liposome Res. 2012;22(1):72-9.
33. Lim SB, Banerjee A, Onyüksel H. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release. 2012;163(1):34-45.
34. Dokoumetzidis A, Karalis V, Iliadis A, Macheras P. The heterogeneous course of drug transit through the body. Trends Pharmacol Sci. 2004;25(3):140-6.
35. Dokoumetzidis A, Papadopoulou V, Valsami G, Macheras P. Development of a reaction-limited model of dissolution: application to official dissolution tests experiments. Int J Pharm. 2008;355:114-25.
36. Dokoumetzidis A, Macheras P. The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional. Pharm Res. 2011;28:1229-32.
37. Pereira LM. Fractal pharmacokinetics. Comput Math Methods Med. 2010;11(2):161-84.
38. Heutault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003;24:4283-300.
39. Ganguly R, Asawal VK. Improved micellar hydration and gelation characteristics of PEO-PPO-PEO triblock copolymer solution in the precence of LiCl. J Phys Chem B. 2008;112:7726-31.
40. Burchard W. Static and dynamic light scattering from branched polymers and biopolymers. Adv Polym Sci. 1983;48:1-124.
41. Belsito B, Bartucci R, Sportelli L. Sterically stabilized liposomes of DPPC/DPPE-PEG:2000. A spin label ESR and spectrophotometric study. Biophys Chem. 1998;75(1):33-43.
42. Silvander M, Hansson P, Edwards K. Liposomal surface potential and bilayer packing as affected by PEG-lipid inclusion. Langmuir. 2000;16:3693-702.
43. Liu F, Liu D. Long-circulating emulsions (oil in water) as carriers for lipophilic drugs. Pharm Res. 1995;12:1060-4.
44. Liu F, Liu D. Serum independent liposome uptake by mouse liver. Biochim Biophys Acta. 1996;1278:5-11.
45. Shimanouchi T, Sasaki M, Hiroiwa A, Yoshimoto N, Miyagawa K, Umakoshim H, et al. Relationship between the mobility of phosphocholine headgroups of liposomes and the hydrophobicity at the membrane interface: a characterization with spectrophotometric measurements. Colloids Surf B Biointerfaces. 2011;88:221-30.
46. Vogtt K, Joworrek C, Garamus VM, Winter R. Microdomains in lipid vesicles: structure and distribution assessed by small-angle scattreing. J Phys Chem B. 2010;114:5643-8.
47. Giraud MN, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol. 1999;57(3):247-54.
48. Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med. 1995;1(2):154-8.
49. Lichtenberger LM, Zhou Y, Dial EJ, Raphael RM. NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol. 2006;58(11):1421-8.
50. Zhou Y, Raphael RM. Effect of salicylate on the elasticity, bebding stiffness, and strength of SOPC. Biophys J. 2005;89(3):1789-801.
51. Lúcio M, Bringezu F, Reis S, Lima JL, Brezesinski G. Binding of nonsteroidal anti-inflammatory drugs to DPPC: structure and thermodynamic aspects. Langmuir. 2008;24(8):4132-9.
52. Nunes C, Brezesinski G, Pereira-Leite C, Lima JL, Reis S, Lúcio M. NSAIDs interactions with membranes: a biophysical approach. Langmuir. 2011;27(17):10847-58.
53. Srinath P, Vyas SP, Diwan PV. Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm. 2000;26(3):313-21.
54. Srinath P, Vyas SP, Diwan PV. Long-circulating liposomes of indomethacin in arthritic rats - a biodisposition study. Pharm Acta Helv. 2000;74(4):399-404.
55. Palakurthi S, Vyas SP, Diwan PV. Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. Int J Pharm. 2005;290:55-62.
56. Zhou Y, Cho KJ, Plownan SJ, Hancock JF. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of Ras proteins on the plasma membrane. J Biol Chem. 2012;287(20):16586-95.